DEFICIENCY OF HOLOCERULOPLASMIN, BUT NOT APOCERULOPLASMIN IN GENETICALLY COPPER-INTOXICATED LEC MUTANT RAT

被引:15
作者
SATO, M
HACHIYA, N
YAMAGUCHI, Y
KUBOTA, J
SAITO, Y
FUJIOKA, Y
SHIMATAKE, H
TAKIZAWA, Y
AOKI, T
机构
[1] TOHO UNIV,SCH MED,DEPT MOLEC BIOL,TOKYO 143,JAPAN
[2] AKITA UNIV,SCH MED,DEPT PUBL HLTH,AKITA 010,JAPAN
[3] TOHO UNIV,SCH MED,DEPT PEDIAT,TOKYO 143,JAPAN
关键词
D O I
10.1016/0024-3205(93)90583-O
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Long-Evans Cinnamon(LEC) mutant rats exhibited less than 5% of normal levels of serum ceruloplasmin oxidase activity, but immunoblot analysis showed normal levels of immunologically detectable ceruloplasmin protein in sera from the mutant rats. Immunostaining of cryosections from the liver tissues with anti-ceruloplasmin antibody showed no significant difference between normal and LEC rats. Results from pulse labeling of ceruloplasmin for 3 hours with [S-35]methionine in primary hepatocyte culture, followed by immunoprecipitation, SDS-PAGE and fluorography, showed only minor changes in ceruloplasmin protein synthesis and secretion. These results suggest that the mutation(s) does not affect ceruloplasmin gene expression, but results in a failure in the mechanism whereby copper is incorporated into newly synthesized apoceruloplasmin to produce oxidase active holoform.
引用
收藏
页码:1411 / 1416
页数:6
相关论文
共 28 条
  • [1] HEPATIC CERULOPLASMIN-GENE EXPRESSION DURING DEVELOPMENT IN THE GUINEA-PIG - CORRELATION WITH CHANGES IN HEPATIC COPPER-METABOLISM
    BINGLE, CD
    EPSTEIN, O
    SRAI, SKS
    GITLIN, JD
    [J]. BIOCHEMICAL JOURNAL, 1991, 276 : 771 - 775
  • [2] BOWCOCK AM, 1987, AM J HUM GENET, V41, P27
  • [3] MOLECULAR STUDIES OF CERULOPLASMIN DEFICIENCY IN WILSONS-DISEASE
    CZAJA, MJ
    WEINER, FR
    SCHWARZENBERG, SJ
    STERNLIEB, I
    SCHEINBERG, IH
    VANTHIEL, DH
    LARUSSO, NF
    GIAMBRONE, MA
    KIRSCHNER, R
    KOSCHINSKY, ML
    MACGILLIVRAY, RTA
    ZERN, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (04) : 1200 - 1204
  • [4] DANKS DM, 1983, METABOLIC BASIS INHE, P1251
  • [5] PREDICTIVE TESTING FOR WILSONS-DISEASE USING TIGHTLY LINKED AND FLANKING DNA MARKERS
    FARRER, LA
    BOWCOCK, AM
    HEBERT, JM
    BONNETAMIR, B
    STERNLIEB, I
    GIAGHEDDU, M
    STGEORGEHYSLOP, P
    FRYDMAN, M
    LOSSNER, J
    DEMELIA, L
    CARCASSI, C
    LEE, R
    BEKER, R
    BALE, AE
    DONISKELLER, H
    SCHEINBERG, IH
    CAVALLISFORZA, LL
    [J]. NEUROLOGY, 1991, 41 (07) : 992 - 999
  • [6] FLEMING RE, 1990, J BIOL CHEM, V265, P7701
  • [7] CERULOPLASMIN - PHYSIOLOGICAL AND PATHOLOGICAL PERSPECTIVES
    GUTTERIDGE, JMC
    STOCKS, J
    [J]. CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1981, 14 (04): : 257 - 329
  • [8] HOLTZMAN NA, 1970, J BIOL CHEM, V245, P2354
  • [9] CERULOPLASMIN IN WILSONS DISEASE
    HOLTZMAN, NA
    NAUGHTON, MA
    IBER, FL
    GAUMNITZ, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (06) : 993 - &
  • [10] CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4
    LAEMMLI, UK
    [J]. NATURE, 1970, 227 (5259) : 680 - +